Home
About
Overview
Sharing Data
ORCID
Help
History (1)
IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells.
IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells. Blood. 2015 May 14; 125(20):3144-52.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Cell Cycle Checkpoints
Cell Line, Tumor
Cell Proliferation
Cell Survival
Cluster Analysis
Disease Models, Animal
Gene Expression
Gene Expression Profiling
Hematopoietic Stem Cells
Humans
Interleukin-8
Leukemia, Myeloid, Acute
Mice
Myelodysplastic Syndromes
Neoplastic Stem Cells
Prognosis
Receptors, Interleukin-8B
Signal Transduction
Xenograft Model Antitumor Assays
authors with profiles
Amittha Wickrema